Loading data
AEHRNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 50 m USD | 58.97 m USD | 66.22 m USD | 64.96 m USD | 50.83 m USD |
| Cost of revenue | 32.35 m USD | 35.04 m USD | 33.68 m USD | 32.22 m USD | 27.16 m USD |
| Gross profit | 17.65 m USD | 23.93 m USD | 32.54 m USD | 32.75 m USD | 23.67 m USD |
| Research and development expense | 12.63 m USD | 10.46 m USD | 8.72 m USD | 7.13 m USD | 5.82 m USD |
| Selling, general and administrative expense | 19.16 m USD | 18.28 m USD | 13.75 m USD | 12.24 m USD | 10.05 m USD |
| Operating profit | -14.15 m USD | -5.68 m USD | 10.08 m USD | 13.38 m USD | 7.8 m USD |
| Profit before tax | -11.74 m USD | -4.29 m USD | 12.46 m USD | 14.62 m USD | 9.54 m USD |
| Income tax expense | -4.61 m USD | -381 k USD | -20.7 m USD | 60 k USD | 91 k USD |
| Net income (reported basis) | -7.13 m USD | -3.91 m USD | 33.16 m USD | 14.56 m USD | 9.45 m USD |
| Basic earnings per share | -0.23 USD/share | -0.13 USD/share | 1.15 USD/share | 0.52 USD/share | 0.36 USD/share |
| Diluted earnings per share | -0.23 USD/share | -0.13 USD/share | 1.12 USD/share | 0.5 USD/share | 0.34 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.